Chikodi Sales PharmaLiability P Artnership Profile
Key Indicators
- Obligation of Contribution ₹ 2.50 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
About Chikodi Sales PharmaLiability P Artnership
Chikodi Sales Pharma Limited Liability P Artnership (CSPLLPA) is 6 Year, 1 Month old Limited Liability Partnership 28 December 2018. Its registered office is in Belgaum, Karnataka, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 2.50 M as per MCA.
Company Details
-
Location
Belgaum, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAN-8643
-
Incorporation Date
28 Dec 2018
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Bangalore
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Chikodi Sales PharmaLiability P Artnership?
Designated Partners (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Kore
|
Designated Partner | 22-Aug-2019 | Current |
|
Sachidananda Halappanavar
|
Designated Partner | 22-Aug-2019 | Current |
|
Satish Patil
|
Designated Partner | 28-Dec-2018 | Current |
|
Sanjeevkumar Mone
|
Designated Partner | 28-Dec-2018 | Current |
Financial Performance of Chikodi Sales PharmaLiability P Artnership.
Enhance accessibility to Chikodi Sales PharmaLiability P Artnership's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chikodi Sales PharmaLiability P Artnership?
Unlock access to Chikodi Sales PharmaLiability P Artnership's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Chikodi Sales Generic Pharma LlpDeepak Kore, Sachidananda Halappanavar and 1 more are mutual person
-
Om Medicine Mall Llp
Sachidananda Halappanavar and Sanjeevkumar Mone are mutual person
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- Idfc First Bank Limited : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2020 | Idfc First Bank Limited | ₹6.00 M | Open |
How Many Employees Work at Chikodi Sales PharmaLiability P Artnership?
Unlock and access historical data on people associated with Chikodi Sales PharmaLiability P Artnership, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chikodi Sales PharmaLiability P Artnership, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chikodi Sales PharmaLiability P Artnership's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.